share_log

The Manufacturers Life Insurance Company Purchases 11,359 Shares of Agilon Health, Inc. (NYSE:AGL)

The Manufacturers Life Insurance Company Purchases 11,359 Shares of Agilon Health, Inc. (NYSE:AGL)

制造商人寿保险公司购买了 Agilon Health, Inc.(纽约证券交易所代码:AGL)的 11,359 股股票
Defense World ·  2023/02/06 05:13

The Manufacturers Life Insurance Company boosted its position in agilon health, inc. (NYSE:AGL – Get Rating) by 27.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 52,327 shares of the company's stock after purchasing an additional 11,359 shares during the period. The Manufacturers Life Insurance Company's holdings in agilon health were worth $1,230,000 as of its most recent SEC filing.

根据制造商人寿保险公司最近提交给美国证券交易委员会的文件,该公司第三季度将其在Agilon Health,Inc.(纽约证券交易所代码:AGL-GET评级)的头寸提高了27.7%。该机构投资者持有52,327股该公司股票,在此期间又购买了11,359股。截至最近提交给美国证券交易委员会的文件,制造商人寿保险公司持有的雅居伦健康公司股份价值123万美元。

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AGL. Barclays PLC grew its holdings in shares of agilon health by 80.0% in the third quarter. Barclays PLC now owns 89,962 shares of the company's stock valued at $2,106,000 after acquiring an additional 39,988 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in agilon health by 52.2% in the 3rd quarter. Los Angeles Capital Management LLC now owns 165,443 shares of the company's stock valued at $3,875,000 after purchasing an additional 56,728 shares during the period. Victory Capital Management Inc. increased its position in shares of agilon health by 4.1% during the 3rd quarter. Victory Capital Management Inc. now owns 23,797 shares of the company's stock valued at $557,000 after purchasing an additional 942 shares during the last quarter. Kestra Advisory Services LLC purchased a new stake in shares of agilon health during the 3rd quarter valued at $1,068,000. Finally, Maryland State Retirement & Pension System boosted its holdings in shares of agilon health by 14.5% in the 3rd quarter. Maryland State Retirement & Pension System now owns 14,658 shares of the company's stock worth $343,000 after buying an additional 1,855 shares during the last quarter.

其他几家机构投资者和对冲基金最近也增持或减持了AGL的股份。巴克莱在第三季度增持了Agilon Health的股票80.0%。巴克莱现在持有89,962股该公司股票,价值2,106,000美元,在上个季度增持了39,988股。第三季度,洛杉矶资本管理公司在Agilon Health的持股增加了52.2%。洛杉矶资本管理有限责任公司在此期间又购买了56,728股,现在拥有165,443股该公司股票,价值3,875,000美元。胜利资本管理公司在第三季度将其在Agilon Health的股票头寸增加了4.1%。胜利资本管理公司目前持有23,797股该公司股票,价值55.7万美元,该公司在上个季度又购买了942股。Kestra Consulting Services LLC在第三季度购买了Agilon Health的新股,价值1,068,000美元。最后,马里兰州退休和养老金系统在第三季度将其在Agilon Health的股票持有量增加了14.5%。马里兰州退休和养老金系统现在拥有14,658股该公司的股票,价值343,000美元,在上个季度又购买了1,855股。

Get
到达
agilon health
雅居隆健康
alerts:
警报:

Insider Transactions at agilon health

Agilon Health的内幕交易

In related news, insider Benjamin Kornitzer sold 5,398 shares of the business's stock in a transaction that occurred on Friday, December 16th. The shares were sold at an average price of $16.82, for a total transaction of $90,794.36. Following the completion of the transaction, the insider now owns 10,426 shares of the company's stock, valued at $175,365.32. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Benjamin Shaker sold 20,723 shares of agilon health stock in a transaction dated Wednesday, January 18th. The stock was sold at an average price of $19.78, for a total transaction of $409,900.94. Following the completion of the sale, the insider now owns 25,625 shares in the company, valued at approximately $506,862.50. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Benjamin Kornitzer sold 5,398 shares of the company's stock in a transaction that occurred on Friday, December 16th. The stock was sold at an average price of $16.82, for a total transaction of $90,794.36. Following the completion of the transaction, the insider now owns 10,426 shares in the company, valued at $175,365.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 39,613 shares of company stock valued at $746,114. 3.30% of the stock is currently owned by corporate insiders.

在相关新闻中,内部人士Benjamin Kornitzer在12月16日星期五的一笔交易中出售了5398股该公司的股票。这些股票以16.82美元的平均价格出售,总成交金额为90,794.36美元。交易完成后,这位内部人士现在拥有该公司10,426股股票,价值175,365.32美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过此超链接。其他消息方面,内部人士本杰明·沙克在1月18日星期三的一笔交易中出售了20,723股雅居隆健康股票。该股以19.78美元的平均价格出售,总成交金额为409,900.94美元。出售完成后,这位内部人士现在拥有该公司25,625股,价值约506,862.50美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过此超链接。此外,内部人士本杰明·科尼策在12月16日星期五的一次交易中出售了5398股该公司股票。该股以16.82美元的平均价格出售,总成交金额为90,794.36美元。交易完成后,这位内部人士现在拥有该公司10,426股,价值175,365.32美元。关于这次销售的披露可以找到这里。在过去的90天里,内部人士出售了39,613股公司股票,价值746,114美元。3.30%的股份目前由企业内部人士持有。

Analysts Set New Price Targets

分析师设定新的价格目标

AGL has been the topic of a number of research analyst reports. Wells Fargo & Company dropped their target price on shares of agilon health from $28.00 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 15th. The Goldman Sachs Group dropped their price objective on agilon health from $38.00 to $34.00 and set a "buy" rating on the stock in a research note on Tuesday, November 15th. SVB Leerink lowered their target price on agilon health from $33.00 to $30.00 and set an "outperform" rating on the stock in a research note on Friday, November 4th. Finally, Stifel Nicolaus initiated coverage on agilon health in a research report on Thursday, December 8th. They set a "buy" rating and a $23.00 price target on the stock. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $28.38.
AGL已经成为许多研究分析师报告的主题。富国银行在11月15日星期二的一份研究报告中将雅居伦健康公司的股票目标价从28.00美元下调至22.00美元,并对该股设定了“增持”评级。11月15日,周二,高盛夫妇在一份研究报告中将雅居伦健康的目标价从38.00美元下调至34.00美元,并对该股设定了买入评级。11月4日,SVB Leerink在一份周五的研究报告中将雅居伦健康的目标价从33.00美元下调至30.00美元,并对该股设定了“跑赢大盘”的评级。最后,Stifel Nicolaus在12月8日星期四的一份研究报告中发起了关于Agilon健康的报道。他们为该股设定了“买入”评级和23.00美元的目标价。一名分析师对该股的评级为持有,七名分析师对该股的评级为买入。根据MarketBeat的数据,该股目前的平均评级为“适度买入”,共识目标价为28.38美元。

agilon health Price Performance

雅居伦健康性价比

Shares of NYSE AGL opened at $22.05 on Monday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.48 and a current ratio of 2.48. agilon health, inc. has a fifty-two week low of $14.82 and a fifty-two week high of $28.36. The stock has a market cap of $9.08 billion, a PE ratio of -84.81 and a beta of 1.09. The stock has a fifty day moving average of $18.19 and a 200-day moving average of $20.57.

周一,纽约证交所AGL的股价开盘报22.05美元。该公司的负债权益比率为0.04,速动比率为2.48,流动比率为2.48。Agilon Health,Inc.的股价为52周低点14.82美元,52周高点28.36美元。该股市值为90.8亿美元,市盈率为-84.81,贝塔系数为1.09。该股的50日移动均线切入位为18.19美元,200日移动均线切入位为20.57美元。

agilon health (NYSE:AGL – Get Rating) last issued its earnings results on Thursday, November 3rd. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02). agilon health had a negative return on equity of 9.31% and a negative net margin of 4.30%. The company had revenue of $694.86 million during the quarter, compared to the consensus estimate of $651.24 million. Equities research analysts anticipate that agilon health, inc. will post -0.21 earnings per share for the current year.

Agilon Health(纽约证券交易所代码:AGL-GET Rating)最近一次发布收益报告是在11月3日星期四。该公司公布本季度每股收益(0.07美元),低于普遍预期的(0.05美元)和(0.02美元)。Agilon Health的股本回报率为负9.31%,净利润率为负4.30%。该公司本季度营收为6.9486亿美元,而市场普遍预期为6.5124亿美元。股票研究公司分析师预计,安捷伦健康公司本年度的每股收益将达到0.21美元。

agilon health Profile

Agilon健康状况简介

(Get Rating)

(获取评级)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Agilon Health,Inc.通过美国社区的初级保健医生为老年人提供医疗服务。截至2021年12月31日,它为大约23.8万名高级成员提供服务,其中包括18.63万名联邦医疗保险优势成员和5.17万名联邦医疗保险按服务收费受益人。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on agilon health (AGL)
  • Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
  • MarketBeat Week in Review – 1/30 – 2/3
  • Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
  • Zimmer Biomet Beats on Earnings, Growth May be Priced In
  • AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
  • 免费获取StockNews.com关于Agilon Health(AGL)的研究报告
  • C3.ai人工智能产品套件是游戏变革者吗?
  • 市场回顾周-1/30-2/3
  • 细价股值得吗?你应该投资细价股吗?
  • Zimmer Biomet盈利节节攀升,增长可能被计入价格
  • 人工智能软件制造商EPAM号称科技板块涨幅最大

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.

获得《雅居伦健康日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收最新新闻和分析师对Agilon Health及相关公司评级的每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发